Guidelines to speed up the diagnosis and treatment of patients with nerve swelling at the back of the eye, known as papilloedema, are being developed by researchers at the University of Bristol.
Using a new computational approach developed to analyse large genetic datasets from rare disease cohorts, researchers at the Icahn School of Medicine at Mount Sinai and colleagues including the University of Bristol, have discovered previously unknown genetic causes of three rare conditions: primary lymphedema (characterised by tissue swelling), thoracic aortic aneurysm disease, and congenital deafness.
Weight and body mass index (BMI) policies introduced by NHS commissioning groups in England are inappropriate and worsening health inequalities, according to a new study published in BMC Medicine today [13 June] that analysed nearly 490,000 hip surgeries. With one in ten people likely to need a joint replacement in their lifetime, many thousands of patients are directly affected by these policies.
Three clinicians based in the Academic Respiratory Unit (ARU) have been successful in gaining prestigious and highly competitive clinical academic funding from the National Institute for Health and Care Research (NIHR) and the Medical Research Council (MRC).
A pneumonia trial – the largest ever – will investigate whether aspirin can reduce the risk of a heart attack or stroke in patients who are admitted to hospital with pneumonia.
Traumatic injuries and violence remain a substantial cause of childhood deaths; before, during and after the pandemic, according to a new report published today [13 July] by the University of Bristol's National Child Mortality Database (NCMD) team.
The success of PReCePT, a programme to increase the use of magnesium sulfate to prevent cerebral palsy in premature babies, has been highlighted in a study led by National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West) researchers including from the University of Bristol.
There are significant variations in healthcare spending and care delivery across NHS hospitals in England and Wales following hip fracture, a new study aimed at understanding how hospital care impacts patients’ outcomes and costs has revealed.
A first-of-its kind hormone replacement therapy that more closely replicates the natural circadian and ultradian rhythms of our hormones has shown to improve symptoms in patients with adrenal conditions. Results from the University of Bristol-led clinical trial are published today [20 October] in the Journal of Internal Medicine.
A potential treatment for the world’s leading cause of kidney failure in children needing dialysis has been discovered by an international team of scientists. The University of Bristol-led breakthrough is published today [19 October] in Med.
